BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 12217440)

  • 1. Pressure-dependent attenuation in ultrasound contrast agents.
    Chen Q; Zagzebski J; Wilson T; Stiles T
    Ultrasound Med Biol; 2002 Aug; 28(8):1041-51. PubMed ID: 12217440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physical and biochemical stability of Optison, an injectable ultrasound contrast agent.
    Podell S; Burrascano C; Gaal M; Golec B; Maniquis J; Mehlhaff P
    Biotechnol Appl Biochem; 1999 Dec; 30(3):213-23. PubMed ID: 10574690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Destruction of contrast agent microbubbles in the ultrasound field: the fate of the microbubble shell and the importance of the bubble gas content.
    Klibanov AL; Hughes MS; Wojdyla JK; Wible JH; Brandenburger GH
    Acad Radiol; 2002 May; 9 Suppl 1():S41-5. PubMed ID: 12019891
    [No Abstract]   [Full Text] [Related]  

  • 4. Contrast agent bubble and erythrocyte behavior in a 1.5-MHz standing ultrasound wave.
    Khanna S; Amso NN; Paynter SJ; Coakley WT
    Ultrasound Med Biol; 2003 Oct; 29(10):1463-70. PubMed ID: 14597343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The disappearance of ultrasound contrast bubbles: observations of bubble dissolution and cavitation nucleation.
    Chen WS; Matula TJ; Crum LA
    Ultrasound Med Biol; 2002 Jun; 28(6):793-803. PubMed ID: 12113792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of microbubble destruction of three fluorocarbon-filled ultrasonic contrast agents.
    Moran CM; Anderson T; Pye SD; Sboros V; McDicken WN
    Ultrasound Med Biol; 2000 May; 26(4):629-39. PubMed ID: 10856626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative measurements of second harmonic Doppler using ultrasound contrast agents.
    Chang PH; Shung KK; Levene HB
    Ultrasound Med Biol; 1996; 22(9):1205-14. PubMed ID: 9123645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Broadband attenuation measurements of phospholipid-shelled ultrasound contrast agents.
    Raymond JL; Haworth KJ; Bader KB; Radhakrishnan K; Griffin JK; Huang SL; McPherson DD; Holland CK
    Ultrasound Med Biol; 2014 Feb; 40(2):410-21. PubMed ID: 24262056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Newtonian rheological model for the interface of microbubble contrast agents.
    Chatterjee D; Sarkar K
    Ultrasound Med Biol; 2003 Dec; 29(12):1749-57. PubMed ID: 14698342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrasonic characterization of the nonlinear properties of contrast microbubbles.
    Shi WT; Forsberg F
    Ultrasound Med Biol; 2000 Jan; 26(1):93-104. PubMed ID: 10687797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the suitability of broadband attenuation measurement for characterizing contrast microbubbles.
    Chatterjee D; Sarkar K; Jain P; Schreppler NE
    Ultrasound Med Biol; 2005 Jun; 31(6):781-6. PubMed ID: 15936494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro acoustic characterisation of four intravenous ultrasonic contrast agents at 30 MHz.
    Moran CM; Watson RJ; Fox KA; McDicken WN
    Ultrasound Med Biol; 2002 Jun; 28(6):785-91. PubMed ID: 12113791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monodisperse Versus Polydisperse Ultrasound Contrast Agents: Non-Linear Response, Sensitivity, and Deep Tissue Imaging Potential.
    Segers T; Kruizinga P; Kok MP; Lajoinie G; de Jong N; Versluis M
    Ultrasound Med Biol; 2018 Jul; 44(7):1482-1492. PubMed ID: 29705522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro acoustic characterization of three phospholipid ultrasound contrast agents from 12 to 43 MHz.
    Sun C; Sboros V; Butler MB; Moran CM
    Ultrasound Med Biol; 2014 Mar; 40(3):541-50. PubMed ID: 24361219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of postexcitation thresholds for single ultrasound contrast agent microbubbles using double passive cavitation detection.
    King DA; Malloy MJ; Roberts AC; Haak A; Yoder CC; O'Brien WD
    J Acoust Soc Am; 2010 Jun; 127(6):3449-55. PubMed ID: 20550244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of ultrasound pulses combined with Definity for targeted blood-brain barrier disruption: a feasibility study.
    McDannold N; Vykhodtseva N; Hynynen K
    Ultrasound Med Biol; 2007 Apr; 33(4):584-90. PubMed ID: 17337109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro characterization of the subharmonic ultrasound signal from Definity microbubbles at high frequencies.
    Cheung K; Couture O; Bevan PD; Cherin E; Williams R; Burns PN; Foster FS
    Phys Med Biol; 2008 Mar; 53(5):1209-23. PubMed ID: 18296758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics and Echogenicity of Clinical Ultrasound Contrast Agents: An In Vitro and In Vivo Comparison Study.
    Hyvelin JM; Gaud E; Costa M; Helbert A; Bussat P; Bettinger T; Frinking P
    J Ultrasound Med; 2017 May; 36(5):941-953. PubMed ID: 28240842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro contrast-enhanced ultrasound measurements of capillary microcirculation: comparison between polymer- and phospholipid-shelled microbubbles.
    Grishenkov D; Kari L; Brodin LK; Brismar TB; Paradossi G
    Ultrasonics; 2011 Jan; 51(1):40-8. PubMed ID: 20542310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Needle and Catheter Size on Commercially Available Ultrasound Contrast Agents.
    Eisenbrey JR; Daecher A; Kramer MR; Forsberg F
    J Ultrasound Med; 2015 Nov; 34(11):1961-8. PubMed ID: 26384606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.